Cool Concept for International Logistics
Mannheim/Germany-based eutecma GmbH with Second Location in the USA
Mannheim/Germany, August 2024 – Mannheim/Germany-based eutecma GmbH is expanding its presence on the North American continent. Following the opening of a refreshment center in Springfield/Ohio last year, the eutecma corporation is now cooperating with a US partner in Wisconsin, the Badger State near the Canadian border, to manufacture environmentally friendly EPS shipping boxes according to eutecma standards.
As a global operator in the packaging sector, eutecma supplies shipping boxes with volumes ranging from 4 to 1588 liters for three different temperature ranges, all assembled from modular components. These boxes are primarily used by customers in the pharmaceutical industry to ship temperature-sensitive products. After utilization, the recipients return the boxes, which are fitted with RFID chips (Radio Frequency Identification), to a refreshment center. Once there, a fully automatic system measures and weighs them, as well as checking that all box parameters comply with the relevant specifications. The goal is to re-use the boxes as many times as possible, deploying them within a circular economy. The cloud-based retecma system provides the customer with information on how many times the boxes and cooling elements have already been used and how much CO2 has been saved. Parts that are in good working order are disinfected with UV radiation and, if necessary, steam cleaned. All damaged components are removed and sent to a recycling company that refurbishes them to create new modules. The result? No loss of materials and virtually zero emissions, reducing CO2 by 97 percent.
To see these cold chain systems, visit LogiPharma, the world’s premier event for global pharmaceutical supply chains and logistics, in Boston from September 23 through 25.
Contacts
Esther Lorenz-Bottkeeutecma gmbh
Tel:+49 621 107 563 02presse@eutecma.deImages
Subscribe to releases from news aktuell GmbH
Subscribe to all the latest releases from news aktuell GmbH by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from news aktuell GmbH
LTS wins funding from BARDA’s Patch Forward Prize Competition for two partnerships14.1.2025 13:05:41 CET | Press Release
Andernach – LTS LOHMANN Therapie-Systeme AG (“LTS”), a leading pharmaceutical technology company, is proud to announces its selection as a Concept Stage winner for two projects in the #PatchForwardPrize, a $50 million challenge by the Biomedical Advanced Research and Development Authority (BARDA) to advance microneedle patch-based RNA vaccine technologies. The Patch Forward Prize, part of the Project NextGen initiative led by BARDA, aims to accelerate next-generation vaccine technologies. By fostering partnerships between vaccine developers and delivery platform innovators, the competition drives progress from concept to clinical stages, paving the way for transformative advancements in global health. Each of the prizes announced today represents an award of US$ 2 million, that will be shared between LTS and its partners. The awarded projects bring together LTS’s proprietary dissolvable Microneedle Array Patch (MAP) technology with mRNA vaccines from two partners, BioNet, a biotech man
FEV develops AI-supported driver monitoring system CogniSafe9.1.2025 11:00:00 CET | Pressmeddelande
Aachen – FEV, a leading global innovation driver for the mobility of tomorrow, presents CogniSafe, a state-of-the-art Driver Monitoring System (DMS) that significantly increases road safety. The system uses advanced technologies such as deep learning and computer vision to monitor driver conditions such as distraction, fatigue and inattention in real time and under even the most challenging conditions.
Grünenthal appoints Prof. Dr. Uli Brödl as Chief Scientific Officer9.1.2025 10:25:56 CET | Press Release
Aachen, Germany, 09 January 2025 – Grünenthal announced today that Prof. Dr. Uli Brödl will assume the role of Chief Scientific Officer (CSO) and Member of the Corporate Executive Board, effective 01 February 2025. Uli Brödl has more than 15 years of industry experience. He joins Grünenthal from Boehringer Ingelheim, where he served as Corporate Senior Vice President, Head of Global Clinical Development & Operations, and member of Boehringer Ingelheim's Venture Fund Investment Committee. In his most recent role, he oversaw end-to-end clinical development and operations activities across therapeutic areas and worked at the interface of R&D, Commercial, and Market Access functions. He has a proven track record of bringing innovative medicines to patients, including Empagliflozin, an oral anti-diabetic medicine. Earlier in his career, Uli Brödl led Boehringer Ingelheim's Canadian medical organisation and gained extensive market experience. In parallel, he founded and co-chaired the BI Can
175 years of Heidelberger Druckmaschinen: Company starts anniversary year with growth strategy8.1.2025 13:11:11 CET | Press Release
Growth strategy: medium-term sales potential of more than € 300 million Growth drivers in the core business: packaging, digital printing Software and lifecycle business Industrial business: focus on further expansion 175 years: the company has been shaping the printing industry for decades with technological innovations, quality and reliability Numerous anniversary activities throughout the year
Assessing risks from pharmaceutical residues: How the APRIORA project is helping communities to improve drinking water quality7.1.2025 08:16:33 CET | Press Release
As part of the EU-funded APRIORA project, drug residues are being analysed. Scientists from the University of Rostock are taking water samples in all weathers. The aim is to use innovative approaches to improve wastewater treatment in Europe.
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom